Ischemic stroke
Conditions
Interventions
Treatment group:drug therapy.The patient took 5 capsules/day for 3 months.
Control group:None
Sponsors
Affiliated Hospital of Shaanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patient enrollment criteria: (1) Meet the diagnostic criteria for acute phase of ischemic stroke; (2) National Institutes of Health Stroke Scale (NIHSS score) : 1 point =NIHSS < 15 points; (3) Ischemic stroke patients who meet the TCM syndrome differentiation as phlegm-stasis interjunction type; (4) Stroke was confirmed by MRI or craniocerebral CT. (5) Age between 40 and 80 years old, gender is not limited; (6) Patients and their families were aware of the general situation of this study and voluntarily signed informed consent. Control group admission criteria: (1) No special medical history, no abnormal findings in physical examination; (2) No history of infection in the past 2 months.
Exclusion criteria
Exclusion criteria: (1) Ischemic stroke caused by brain injury, liver and kidney insufficiency, heart insufficiency, immune deficiency, blood disease, hereditary vascular disease, drug abuse and other diseases; (2) Patients with severe cardiovascular, liver, kidney, hematopoietic and endocrine and immune system diseases; (3) Patients with mental disorders or mental disorders; (4) Cancer and tumor patients; (5)Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-LOX;LTB4;TNF-a;IL-6;TC;TG;HDL-C;LDL-C;NIHSS;HAMD-17; | — |
Secondary
| Measure | Time frame |
|---|---|
| hs-CRP;Hcy;APTT;PT;FIB;TCM syndrome score scale; | — |
Countries
China
Contacts
Public ContactBin Wang
Shaanxi University of Chinese Medicine
Outcome results
None listed